Jonathon Unwin
Stock Analyst at Barclays
(0.15)
# 4,303
Out of 4,421 analysts
50
Total ratings
12%
Success rate
-24.6%
Average return
Main Sectors:
Stocks Rated by Jonathon Unwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: YPSN Ypsomed Holding AG | Maintained: Buy | CHF 276.07 → CHF 386.00 | $344.60 | +12.01% | 5 | May 21, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Rated: Hold | €30.00 → €28.00 | $24.84 | +12.72% | 9 | May 13, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Hold | €16.00 | $17.34 | -7.73% | 12 | May 13, 2026 | |
| ETR: GXI Gerresheimer AG | Downgraded: Sell | €23.00 → €19.00 | $25.94 | -26.75% | 7 | Apr 28, 2026 | |
| STO: VIMIAN Vimian Group AB (publ) | Maintained: Sell | kr 25.00 | $29.60 | -15.54% | 11 | Mar 27, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Maintained: Buy | 129p → 172p | $114.60 | +50.09% | 6 | Mar 25, 2026 |
Ypsomed Holding AG
May 21, 2026
Maintained: Buy
Price Target: CHF 276.07 → CHF 386.00
Current: $344.60
Upside: +12.01%
Carl Zeiss Meditec AG
May 13, 2026
Rated: Hold
Price Target: €30.00 → €28.00
Current: $24.84
Upside: +12.72%
SCHOTT Pharma AG & Co. KGaA
May 13, 2026
Maintained: Hold
Price Target: €16.00
Current: $17.34
Upside: -7.73%
Gerresheimer AG
Apr 28, 2026
Downgraded: Sell
Price Target: €23.00 → €19.00
Current: $25.94
Upside: -26.75%
Vimian Group AB (publ)
Mar 27, 2026
Maintained: Sell
Price Target: kr 25.00
Current: $29.60
Upside: -15.54%
Oxford Nanopore Technologies plc
Mar 25, 2026
Maintained: Buy
Price Target: 129p → 172p
Current: $114.60
Upside: +50.09%